The mouse urokinase-type plasminogen activator (uPA) gene was used as a model macrophage colonystimulating factor 1 (CSF-1)-inducible gene to investigate CSF-1 signalling pathways. Nuclear run-on analysis showed that induction of uPA mRNA by CSF-1 and phorbol myristate acetate (PMA) was at the transcriptional level in bone marrow-derived macrophages. CSF-1 and PMA synergized strongly in the induction of uPA mRNA, showing that at least some components of CSF-1 action are mediated independently of protein kinase C. Promoter targets of CSF-1 signalling were investigated with NIH 3T3 cells expressing the human CSF-1 receptor (c-fms). uPA mRNA was induced in these cells by treatment with CSF-1, and a PEA3/AP-1 element at ؊2.4 kb in the uPA promoter was involved in this response. Ets transcription factors can act through PEA3 sequences, and the involvement of Ets factors in the induction of uPA was confirmed by use of a dominant negative Ets-2 factor. Expression of the DNA binding domain of Ets-2 fused to the lacZ gene product prevented CSF-1-mediated induction of uPA mRNA in NIH 3T3 cells expressing the CSF-1 receptor. Examination of ets-2 mRNA expression in macrophages showed that it was also induced synergistically by CSF-1 and PMA. In the macrophage cell line RAW264, the uPA PEA3/AP-1 element mediated a response to both PMA and cotransfected Ets-2. uPA promoter constructs were induced 60-to 130-fold by Ets-2 expression, and the recombinant Ets-2 DNA binding domain was able to bind to the uPA PEA3/AP-1 element. This work is consistent with a proposed pathway for CSF-1 signalling involving sequential activation of fms, ras, and Ets factors.
Macrophage colony-stimulating factor (CSF-1) acts primarily on cells of the mononuclear phagocyte lineage to control growth, differentiation, and survival of precursors as well as functional modulation of mature macrophages (59) . The cell surface receptor for CSF-1 (CSF-1R) is a tyrosine kinase, the product of the c-fms proto-oncogene (reviewed in references 59 and 68), first identified by its homology to the viral oncogene v-fms from the McDonough feline sarcoma virus (69) . Binding of CSF-1 is required for the kinase activity of the normal CSF-1R, whereas the v-fms product is constitutively active. The CSF-1R is most closely related to the plateletderived growth factor receptor and the c-kit gene product (59) .
When CSF-1 binds to its receptor, a range of cellular proteins and the receptor itself are phosphorylated (22) . Like the platelet-derived growth factor receptor, CSF-1R binds and activates the 85-kDa subunit of phosphatidylinositol 3Ј kinase (55) , but the role of phosphatidylinositol 3Ј kinase in signal transduction is not known. Other proteins which become tyrosine phosphorylated in response to CSF-1 include src family kinases (17) , tyrosine phosphatase PTP-1C (84) , Shc proteins, and an uncharacterized 150-kDa protein potentially involved in the ras signalling pathway (43) , although these may not all be direct substrates of the receptor. The ras GTPase-activating protein (GAP)-associated proteins p62 and p190, and to a small extent GAP itself, have been reported to be phosphorylated in response to activated CSF-1R in fibroblasts (31, 55) , but this has not been observed with macrophages (55) .
Some of the actions of CSF-1 are mimicked by the protein kinase C (PKC) agonist phorbol myristate acetate (PMA) (75) , leading to speculation about the role of PKC in CSF-1 signalling. Evidence for an increase in production of diacylglycerol (an activator of PKC) after CSF-1 treatment of monocytes and bone marrow-derived macrophages (BMM) (34, 76) and for an increase in membrane-bound PKC activity (34, 66) has been presented, but recent experiments fail to support these findings (35) . The generation of diacylglycerol is commonly the result of activation of phospholipase C-␥, an enzyme which cleaves phosphatidylinositol-4,5-bisphosphate to diacylglycerol and inositol-1,4,5-trisphosphate. Unlike the platelet-derived growth factor receptor, CSF-1R does not activate phospholipase C-␥ (21), and there is no associated increase in phosphatidylinositol turnover (34, 81 ). An alternative route for diacylglycerol production may be by activation of a phosphatidylcholine-specific phospholipase C (83) .
Evidence from a number of groups points to CSF-1-activated mitogenic signal pathways involving activation of fms, ras, raf, Ets, and myc factors (7, 9, 39, 60) . This may not be a simple linear pathway, as recent experiments with a macrophage cell line showed that activation of Raf-1 was independent of ras (10) . The involvement of p21 ras is well established in experiments with fibroblasts. CSF-1 treatment of c-fms-expressing NIH 3T3 cells and BAC1.2F5 macrophages increased the amount of active GTP-bound p21 ras (10, 26, 31) . Microinjection of anti-p21 ras antibodies into v-fms-transformed fibroblasts caused reversion of the transformed phenotype (70) , as did overexpression of the catalytic domain of GAP (7) and expression of a dominant negative Ets protein (39) . Raf-1 was activated by CSF-1 treatment, and expression of oncogenic v-raf in a macrophage cell line led to CSF-1-independent growth and constitutive expression of ets-2 and c-myc mRNAs (9) . Mutation of the CSF-1R at tyrosine 809, an autophosphor-ylation site, prevented the mitogenic response to CSF-1 and impaired induction of c-myc, while induction of c-fos and junB was unaffected (60, 64) . The mitogenic response could be restored by either c-myc (60) , ets-2 (39), or ets-1 (61) expression.
Progress in defining promoter targets of CSF-1 action has been made in studies of the long terminal repeat of NVL3, a member of the VL30 family of mouse retrotransposons. A ras-responsive promoter element which also mediated a response to CSF-1 in NIH 3T3 fibroblasts expressing c-fms was found (7) . The sequence element is a compound PEA3/AP-1-like site (54) . Additional evidence for the role of p21 ras in the CSF-1 signalling pathway was obtained by showing that the catalytic domain of GAP inhibited fms-mediated activation of this element (7) . Expression of a dominant negative Ets protein (Ets-2 DNA binding domain-LacZ fusion protein), which presumably binds the PEA3 sequence, also prevented CSF-1 activation of this element (39) . This work provided good evidence for the roles of p21 ras and Ets factors in both CSF-1-mediated mitogenesis and induction of the NVL3 gene. More recent data have implicated Ets factors in c-myc induction by CSF-1 (61) , in regulation of the CSF-1-responsive macrophage scavenger receptor gene (82) , and in CSF-1-mediated induction of the c-fos gene (33) .
The ultimate aim of studies of growth factor-activated signal transduction is to find all the molecular links from ligand binding at the cell surface to transcription factor activation and gene induction. Studies of nuclear targets of CSF-1 action in macrophages have been hampered by a lack of well-characterized genes which are induced by CSF-1 in transfectable cell lines, as primary macrophages and macrophage-like cell lines are difficult to transfect efficiently (73) . This paper addresses the regulation of urokinase-type plasminogen activator (uPA), which is acutely regulated by CSF-1 in mature macrophages.
uPA is a serine protease which cleaves the proenzyme plasminogen to plasmin, a protease of broad specificity (reviewed in references 18 and 52). Plasmin directly catalyzes the degradation of the extracellular matrix and also acts indirectly by activating other proenzymes such as procollagenase. uPA activity is associated with processes which require tissue remodelling or cell movement, such as wound healing and involution of the mammary glands, and is frequently expressed at the invading front of cancerous tissue. Since macrophage function requires migration through tissues, uPA may be required to allow the necessary extracellular matrix degradation. uPA activity was first shown to be induced by CSF-1 in bone marrowderived macrophages (BMM) (42) . Accumulation of uPA mRNA in response to CSF-1 has been confirmed to occur in BMM (30) and in the macrophage-like cell line RAW264 (72) . The level of macrophage or monocyte uPA mRNA has also been found to be increased by PMA (30) and gamma interferon (15) and decreased by dexamethasone and cyclic AMP (cAMP) agonists such as cholera toxin (15) .
In this work we have examined the regulation of the uPA gene by CSF-1 and PMA. These agents synergistically induced uPA mRNA in macrophages, suggesting divergent pathways of activation. The difficulty of transfecting primary macrophages has meant that other cell types have had to be used for transient-transfection analysis. A PEA3/AP-1-like element at Ϫ2430 of the mouse uPA promoter was shown to be important in the induction of the gene by PMA in RAW264 cells and by CSF-1 in NIH 3T3 cells expressing c-fms. This element was first described by Rørth et al. (56) as being required for induction of uPA transcription by PMA and epidermal growth factor in keratinocytes. The element is conserved in mouse, pig, and human promoters (12) and is required for induction by PMA in a pig kidney epithelial cell line (41) and by PMA and basic fibroblast growth factor in NIH 3T3 cells (5) . Hence, diverse signalling pathways can converge on this one element. Here we provide evidence that Ets-2 can bind and activate transcription through this element.
MATERIALS AND METHODS
Materials. Recombinant human CSF-1 was kindly provided by Chiron Corp. PMA was obtained from Sigma.
Cell culture. BALB/c BMM were differentiated in culture with CSF-1 as previously described (73) . The RAW264 macrophage-like cell line (53) is derived from tumor cells of an Abelson leukemia virus-infected mouse. This cell line was routinely grown in bacteriological petri dishes in RPMI 1640 medium with 5% fetal calf serum. NIH 3T3 fibroblasts, NIH 3T3 cells expressing human c-fms (63) , and NIH 3T3 cells expressing both c-fms and the human Ets-2 DNA binding region fused to lacZ (39) were cultured in Dulbecco modified Eagle medium supplemented with 10% fetal calf serum.
Northern (RNA) analysis. Total RNA was extracted from cells by the method of Chomczynski and Sacchi (13) . Total RNA (10 g) was run on MOPS (morpholinepropanesulfonic acid)-formaldehyde denaturing gels, transferred to Hybond N nylon membranes, and hybridized with 32 P-labelled DNA probes. The probes used were mouse uPA, a 1.2-kb PstI cDNA fragment (4); mouse Ets-2, excised from the plasmid Ets.pECE (obtained from R. Maki, La Jolla Cancer Research Foundation); 18S rRNA, a 24-bp oligonucleotide complementary to murine 18S rRNA (5ЈCAT GGT AGG CAC GGC GAC TAC CAT3Ј); and human K-rev-1 (rap 1A), a gene fragment obtained by PCR.
Nuclear run-on analysis. The plasmids used were pGEM2 (Promega) (as a control); uPA 5Ј, a genomic fragment of mouse uPA from ϩ8 to ϩ398 (including exon 1, intron 1, and the beginning of exon 2) in pBluescript; uPA3Ј, a fragment encompassing bp 424 to 1643 of the 2.3-kb mouse uPA cDNA in pGEM2; ␤-actin, a 1.8-kb chicken ␤-actin cDNA fragment in pGEM2; c-fms, p755 containing the 3. Filters were prehybridized and hybridized in 5ϫ SSPE (1ϫ SSPE is 0.18 M NaCl, 10 mM NaH 2 PO 4 , and 1 mM EDTA [pH 7.7]), 5ϫ Denhardt's solution, 0.5% sodium dodecyl sulfate (SDS), 50 g of denatured herring sperm DNA per ml, and 200 g of yeast tRNA per ml at 42ЊC in small glass scintillation vials inside rolling hybridization bottles. The prehybridization solution was removed after at least 6 h of incubation, and equivalent counts of RNA from each sample in 0.5 ml of hybridization solution were added. Hybridization proceeded for 36 h. The filters were washed twice for 20 min each time with 2ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at 42ЊC, twice for 20 min each time with 1ϫ SSC-0.1% SDS at 55ЊC, and once for 30 min with 2ϫ SSC with 10 g of RNase A at 37ЊC and finally were rinsed several times in 2ϫ SSC. The filters were exposed for 2 days to 2 weeks.
Transfection analysis. RAW264 cells were transfected by electroporation with 10 g of plasmid DNA as described previously (73) . We found that the voltage needed to be optimized for the individual electroporator in use, as delivered voltages differed from the readout values. puPACAT2 plasmids containing the mouse uPA promoter linked to the chloramphenicol acetyltransferase (CAT) gene (see Fig. 3E ) have been described (12) . Plasmid pPR99, constructed by Rørth et al. (56) , contains a 90-bp HaeIII fragment of the mouse uPA promoter (Ϫ2446 to Ϫ2356) linked to the uPA proximal promoter (Ϫ114 to ϩ398) and the Escherichia coli CAT gene. The related plasmids pPR119 and pPR127 contain point mutations in the PEA3/AP-1 site of the HaeIII fragment (56) (see Fig. 3E ). pPR126 contains only the proximal promoter (Ϫ114 to ϩ398) and the CAT gene. Plasmid pGLuPA-6.6 contains the same promoter region (Ϫ6616 to ϩ398) as puPACAT2, inserted into the HindIII site of the luciferase reporter plasmid pGL2-Basic (Promega). Plasmid pGL99 is equivalent to pPR99 but drives the luciferase reporter gene. The mouse Ets-2 expression vector Ets.pECE and PU.1 expression vector PU.pECE were obtained from R. Maki Canada) was inserted into a cytomegalovirus promoter-driven expression plasmid. The expression vector pECE (23) was used as a control in cotransfection experiments. CAT assays were performed as described previously (12), and luciferase assays were performed as described in Promega protocols. Total protein was assayed with a Bio-Rad Bradford assay kit. NIH 3T3 fibroblasts were transfected by calcium phosphate coprecipitation and assayed for secreted human placental alkaline phosphatase as described previously (49) . The v-fms expression plasmid pSMFeSV (62) was used in cotransfections.
Electrophoretic mobility shift analysis (EMSA). Extracts were prepared from approximately 3 ϫ 10 7 BMM nuclei by a modification of the method of Osborn et al. (48) . Cells were harvested, washed with PBS, and resuspended in 5 ml of hypotonic wash buffer (HWB) (10 mM HEPES [N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid] [pH 7.9], 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA [ethylene glycol-bis(␤-aminoethyl ether)-N,N,NЈ-NЈ-tetraacetic acid]). After the extracts were pelleted and resuspended in 0.5 ml of HWB, 1 ml of HWB containing 0.05% Nonidet P-40 was added. Nuclei were spun down (500 ϫ g, 5 min, 4ЊC; Heraeus Biofuge) and resuspended in 50 to 100 l of nuclear extraction buffer (20 mM HEPES [pH 7.9], 0.42 M NaCl, 20% glycerol, 0.2 mM EDTA, 0.2 mM EGTA) and left on ice for 10 min. Nuclei were spun down (15,000 ϫ g, 10 min, 4ЊC; Heraeus Biofuge) and the supernatant was removed and stored at Ϫ20ЊC. All solutions were ice cold and contained 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 10 g of leupeptin per ml, and 10 g of aprotinin per ml. Protein extract (1 to 5 g in 2 l of nuclear extraction buffer) was incubated with 0.027 pmol of end-labelled double-stranded oligonucleotide probe in a total volume of 10 l containing 20 mM HEPES (pH 7.9), 0.5 mM dithiothreitol, 12% glycerol, 50 mM NaCl, 0.5 g of poly[d(I-C)], and 1 mM EDTA. After the addition of protein, samples were incubated at room temperature for 30 min and run on 5 to 6% acrylamide gels (acrylamide-to-bis ratio, 29:1) at 100 V in 0.5ϫ Tris-borate-EDTA buffer. The gels were dried and visualized by autoradiography.
Mouse Ets-2 DNA binding domain (amino acids 334 to 466) was expressed in E. coli as a glutathione S-transferase (GST) fusion protein with the vector pGEX2T (Pharmacia). Protein was purified with glutathione-agarose (Sigma), and 10 ng of protein was used in EMSA as described above, with the omission of poly[d(I-C)] from the binding reaction. Expressed and purified GST protein was used as a control.
RESULTS
Northern analysis of uPA in macrophages. The effects of CSF-1 and PMA on uPA mRNA levels were examined with BMM and the CSF-1-independent macrophage-like cell line RAW264 (Fig. 1 ). Cells were plated overnight either with or without CSF-1 and then either harvested or treated for a further 4 h with PMA. The level of uPA mRNA was approximately 40-fold higher in CSF-1-treated BMM than in CSF-1-starved cells. The decline in uPA mRNA level with overnight CSF-1 starvation is fully reversible with the readdition of CSF-1 (71), so the decrease in mRNA level is not due to cell death. RAW264 cells also responded to CSF-1, giving an induced level of uPA mRNA that was approximately 25% of that in CSF-1-treated BMM. In six experiments, RAW264 cells responded to CSF-1 with three-to sixfold inductions of uPA mRNA during 8-to 24-h incubations (71, 72) . In experiments examining the time course of induction of uPA mRNA by CSF-1 in both BMM and RAW264 cells, mRNA levels were increased after 1 to 2 h, reached a maximum at 8 to 16 h, and remained elevated above basal levels thereafter, provided that CSF-1 concentrations remained saturating (25, 30, 72) .
The tumor-promoting phorbol ester PMA is believed to exert most of its effects by activation of PKC. PMA alone had a moderate effect on uPA levels in BMM but gave a very large increase in uPA levels in RAW264 cells (Fig. 1) . It has been suggested that similarities in the actions of CSF-1 and PMA in macrophages are due to a common activation of PKC (75) . If PMA and CSF-1 both induce uPA by activation of PKC, then treatment with optimal concentrations of the two agents together should not have an additive effect. Adding PMA to CSF-1-pretreated BMM increased uPA mRNA levels 400-fold above the level for CSF-1-starved cells (Fig. 1 ). Since CSF-1 and PMA added alone gave 40-and 20-fold inductions, respectively, this effect is much greater than additive. The synergism of the two factors added at saturating concentrations indicates that CSF-1 does not induce uPA by merely activating PKC in a manner similar to that of PMA. Although CSF-1 and PMA may activate some of the same pathways, they do so in distinct manners such that synergy is possible. In RAW264 cells the effect of CSF-1 and PMA together was also more than additive. The effect was less striking than in BMM because of the large level of induction by PMA alone.
Ets family transcription factors are implicated in CSF-1 induction of the NVL3 and c-myc genes and in mitogenesis in fibroblasts (39, 61) . Ets factors are a family defined by homology to the v-Ets oncogene product of E26 erythroblastosis virus and include the products of the ets-1, ets-2, erg, fli-1, spi-1 (PU.1), elf-1, and PEA3 genes (78) . PU.1 is a macrophage-and B-cell-specific transcription factor (57), but PU.1 expression and interaction with its target sequence are not affected by CSF-1 (58). Ets-2 protein and mRNA were found to be induced in chicken BMM by the chicken myelomonocytic growth factor and PKC activators (8) . In the mouse macrophage cell line BAC1.2F5, ets-2 mRNA was induced by CSF-1 (9). Examination of ets-2 mRNA expression in macrophages showed induction by PMA and CSF-1 closely paralleling that of uPA mRNA, with apparent synergism between the two stimuli ( Fig.  1) . A time course of the response to CSF-1 in BMM showed a peak of ets-2 mRNA expression at 1 to 2 h, preceding the major induction of uPA (25) . In RAW264 cells, the response of ets-2 mRNA to CSF-1 was barely detectable even at 2 h (25), although the message was induced by PMA (Fig. 1) . The possibility that transcription factor Ets-2 can regulate uPA expression is addressed later in this paper. If induction of Ets-2 is a prerequisite for uPA induction, then it would be anticipated that blockage of protein synthesis would prevent uPA induction. Investigations of such events are difficult, as both ets-2 mRNA and uPA mRNA are induced in macrophages by cycloheximide (14, 25) .
Effects of PMA and CSF-1 on rates of transcription. Nuclear run-on analyses were performed to establish whether the increases in mRNA levels observed with PMA and CSF-1 were due to transcriptional activation. Figure 2A shows results of an analysis of the rates of transcription of a number of genes in BMM treated with CSF-1 and PMA. Two mouse uPA clones were used. uPA 5Ј is a genomic clone containing the noncoding first exon, the first intron, and the beginning of exon 2. uPA 3Ј is a cDNA clone containing bp 424 to 1643 (exons 5 to 11) of the 2.3-kb uPA mRNA (4, 20) . These two clones were used in order to distinguish between effects on initiation of transcription and effects on elongation. Earlier results have shown transcriptional termination or pausing in the second intron of the uPA gene in both fibroblasts and thioglycolate-elicited peritoneal macrophages (3). The results here do not suggest that release of a transcriptional blockage is a major form of regulation of the uPA gene in BMM or RAW264 cells. Both CSF-1 and PMA gave a clear increase in the rate of transcription of uPA in BMM ( Fig. 2A) . In RAW264 cells, PMA treatment increased the rate of transcription, but there was no detectable change when cells were treated with CSF-1 for either 4 or 12 h (Fig. 2B ). This suggests that the moderate level of induction of uPA mRNA by CSF-1 in RAW264 cells ( Fig. 1) occurs at a posttranscriptional level. The rates of uPA transcription in BMM and RAW264 cells were compared by using equivalent counts per minute of run-on transcripts from the two cell types (Fig. 2B) . Such an approach assumes that the total nascent transcripts produced per cell per unit of time is independent of the cell type. This is unlikely to be the case, as RAW264 cells proliferate more rapidly than BMM. However, even if it is assumed that RAW264 nuclei incorporated twice as much radiolabel as BMM nuclei, the rate of transcription of uPA in BMM treated with CSF-1 was still apparently much greater than in RAW264 cells with or without CSF-1 (Fig. 2B) . The results of Northern and nuclear run-on analyses suggest that the CSF-1 responsiveness of the uPA gene is impaired in RAW264 cells compared with that in BMM. CSF-1 and PMA treatments also affected the transcription of other genes studied. In both RAW264 cells and BMM, transcription of c-fms and the lysozyme gene, which are macrophage marker genes, was reduced by CSF-1 and PMA. Both of these agonists are known to down-regulate c-fms mRNA in these cells (85) .
Promoter studies in RAW264 cells. In previous work, we showed that RAW264 cells could be effectively transfected by electroporation but that BMM could not be transfected by the same method because of DNA-dependent cell death (73) . Unfortunately no macrophage cell line which is readily transfectable and gives a good transcriptional response to CSF-1 has yet been identified. Previously reported analysis of the mouse uPA promoter in RAW264 cells (12) showed that maximal expression required the first intron and 6.6 kb of promoter sequence. The full-length (6.6-kb) uPA promoter was induced sixfold by PMA, but no induction was seen with CSF-1 (72) . Basal expression of the pig promoter transfected into RAW264 cells was dependent on the PEA3/AP-1 element first described by Rørth et al. (12, 56) .
Rørth et al. (56) prepared plasmid pPR99 containing a 90-bp HaeIII fragment with the PEA3/AP-1 element (Ϫ2446 to Ϫ2356) linked to the uPA-proximal promoter region (Ϫ114 to ϩ398) and the CAT reporter gene (Fig. 3E) . The activity of this construct in RAW264 cells was compared with that of the full-length promoter in puPACAT2 (Ϫ6.6 kb to ϩ398) and that of the promoter truncated to Ϫ2657. Truncation of the promoter to Ϫ2657 reduced the basal level of expression (12) but gave little change in PMA inducibility (Fig. 3A) . Thus, regions upstream of Ϫ2657 have enhancer activity (12) but are not required for the PMA response. The PMA-induced level of expression from pPR99 is seven to eight times that of the full-length promoter in puPACAT2. The higher level of inducibility may be due to the deletion of inhibitory regions, such as those found in the human promoter between Ϫ660 and Ϫ338 (11) and between Ϫ1824 and Ϫ1572 (77), both of which are 3Ј to the PEA3/AP-1 element.
Mutating either the PEA3 half (plasmid pPR119) or the AP-1 half (plasmid pPR127) (56) of the PEA3/AP-1 site greatly reduced the PMA response (Fig. 3B) . As the basal level of expression from these plasmids was very close to the experimental background level, it was not possible to accurately determine the fold induction by PMA. Using analogous constructs in a luciferase vector in which low-level activity is more easily detectable, we showed that the PEA3 and AP-1 mutations caused only a 50% drop in activity (25) . Hence, the reductions in PMA-induced activity in pPR119 and pPR127 are not likely to be due to a drop in basal expression. The PEA3/AP-1 element can mediate a response to PMA in RAW264 cells, and both halves of the site are required for maximal induction. A plasmid with only the uPA-proximal promoter (Ϫ114 to ϩ398), pPR126, was not PMA responsive (Fig. 3B) . Figure 1 shows that the expression of ets-2 mRNA closely paralleled that of uPA. The ets-2 and uPA genes may be regulated together through common pathways, or Ets-2 levels may control uPA mRNA levels. Since the peak of ets-2 mRNA expression precedes most of the uPA mRNA induction (25) and PEA3 sequences are bound by Ets family transcription factors (79) , the second possibility is an attractive hypothesis. The relatively impaired response of RAW264 cells to CSF-1 may be a consequence of the failure to induce Ets-2. For this reason, the effect of Ets-2 expression on promoter activity in RAW264 cells was examined. Figure 3C shows the results of the cotransfection of an Ets-2 expression plasmid (Ets.pECE) with pPR99 and mutated constructs into RAW264 cells. Ets-2 expression dramatically increased the activity of the uPA promoter in pPR99. Mutations of the PEA3 site (pPR119) and the AP-1 site (pPR127) both reduced the response to cotransfected Ets-2. It is likely that Ets-2 activates transcription directly through the PEA3/AP-1 site, but the possibility that Ets-2 induces another factor involved in transactivation cannot be ruled out. The fact that the AP-1 mutation decreases the response to Ets-2 emphasizes the compound nature of this element; both halves of the element are required for full enhancer activity. The uPA proximal promoter region alone in pPR126 did not respond to Ets-2. The residual Ets-2 response seen with the PEA3/AP-1 mutant constructs pPR119 and pPR127 may be due to another region within the 90-bp HaeIII fragment which has a potential Ets factor binding sequence (GGAT at Ϫ2396 bp in the mouse promoter). This sequence is not perfectly conserved among mouse, pig, and human promoters (12), and whether it has an enhancer function has not been established. Transactivation of the uPA promoter is not a property of all Ets factors. Figure 3D shows results of cotransfection of uPA promoter constructs with expression vectors for the Ets family members Ets-2, Elf-1, PU.1, and PEA3. The promoter constructs used were pGLuPA-6.6, which contains the same promoter region as puPACAT2 (Ϫ6616 to ϩ398) linked to the luciferase reporter gene, and pGL99, which is a luciferase version of pPR99 (Fig. 3E) . For both plasmids, the induction by Ets-2 was 60-to 130-fold. It should be noted that the level of luciferase activity from pGL99 was approximately 25% of that from pGLuPA-6.6. Expression of PU.1 and Elf-1 had little or no effect on promoter activity, and PEA3 gave only a modest increase compared with that of Ets-2. Although native PU.1 is expressed relatively highly in RAW264 cells (57), we still observe some transactivation by coexpressed PU.1 on several other promoters. Our previous work showed that PU.1 from RAW264 nuclear extracts did not bind the uPA PEA3/AP-1 element under EMSA conditions (12) . An Ets-1 expression vector gave the same magnitude of response as Ets-2 (result not shown). Ets-1 is not a good candidate for regulating expression in macrophages, as it is expressed strongly in lymphoid cells but not in macrophage or myeloid cell lines (37) .
Consistent with the results of nuclear run-on (Fig. 2) , which show little effect of CSF-1 on uPA gene transcription in RAW264 cells, no activation of the uPA promoter by CSF-1 was detected in transfection analyses with this cell line (72) . Stably integrated full-length (6.6-kb) promoter was also not responsive to CSF-1 (25) . Results of transient and stable transfection therefore support the idea that the three-to sixfold induction of uPA mRNA in RAW264 cells over an 8-to 16-h treatment with CSF-1 ( Fig. 1) (71, 72) is largely a posttranscriptional effect.
Regulation of the uPA gene by CSF-1 in NIH 3T3 cells. As transcriptional regulation of uPA by CSF-1 in RAW264 cells could not be demonstrated, the regulation of uPA was examined with a heterologous system, i.e., with NIH 3T3 fibroblasts expressing the human CSF-1R, c-fms (referred to herein as NIH 3T3/c-fms). The kinetics of stimulation of uPA mRNA expression by the addition of recombinant human CSF-1 to NIH 3T3/c-fms are depicted in Fig. 4 . The level of uPA mRNA was rapidly stimulated by CSF-1 in these cells, increasing by eightfold within 1 h. The level thereafter declined but at 2 and 4 h remained threefold higher than in unstimulated cells. This level of expression was maintained even after 24 h of CSF-1 stimulation (16) . The kinetics of induction are in contrast to the results found for CSF-1 stimulation of uPA mRNA in BMM (71) or RAW264 cells (72) , in which expression peaks at 8 to 16 h. Similarly, the NVL3 retrotransposon in NIH 3T3/cfms is maximally induced 16 to 24 h after CSF-1 stimulation (7).
To examine the role of Ets proteins in the induction of uPA, we next examined the effect of a dominant negative repressor of Ets action. Stable expression of the DNA binding domain of human Ets-2 fused to the lacZ gene product (39) with c-fms in NIH 3T3 cells prevented CSF-1 induction of uPA mRNA (Fig.   4 ). This is similar to the result obtained for CSF-1 stimulation of NVL3 expression in NIH 3T3/c-fms. The NVL3 gene contains a PEA3/AP-1-like element which behaves as both a rasresponsive element and a CSF-1-responsive element (7) . The possibility that the uPA PEA3/AP-1 element can behave as a CSF-1-responsive element was addressed by transient transfections into NIH 3T3 cells.
uPA promoter activity in NIH 3T3/c-fms. Promoter elements involved in the CSF-1 response of NIH 3T3/c-fms were analyzed by transient transfection. Plasmid pPR99 and the mutant plasmids pPR119 and pPR127 (56) were transfected into NIH 3T3 cells with and without cotransfected v-fms expression plasmid, which encodes a constitutively active form of the CSF-1R (62) (Fig. 5A) . The basal level of activity of pPR99 was low in NIH 3T3 cells, but v-fms expression activated this reporter by an average of 25-fold in three separate experiments. In contrast, the activities of reporters that contained point mutations in either the PEA3 site (pPR119) or the AP-1 site (pPR127) were not greatly stimulated by v-fms. In a second set of experiments, reporters were transfected into NIH 3T3/c-fms cells and stimulation by CSF-1 was determined (Fig. 5B) . In these experiments, pPR99 activity was stimulated three-to fourfold, while the activities of pPR119 and pPR127 were not significantly affected by the ligand-activated CSF-1R. The CSF-1-mediated increase in uPA mRNA (Fig. 4) is therefore likely to involve activation of the PEA3/AP-1 element and requires Ets family transcription factors.
Proteins binding the PEA3/AP-1 element. The transienttransfection analyses described above implicate AP-1 or cAMP response element (CRE)-binding and Ets family transcription factors in the action of CSF-1 and PMA. EMSA was performed in order to determine whether AP-1 transcription factors are able to bind the octameric AP-1 site of the uPA element and whether any proteins binding the PEA3 site are detectable.
In EMSA the uPA PEA3/AP-1 element (uPA wt oligonucleotide) formed two major complexes with nuclear proteins from CSF-1-treated BMM (Fig. 6A) . These complexes were abolished by mutation of the AP-1 half of the element (uPA VOL. 15, 1995 REGULATION OF UROKINASE EXPRESSION BY CSF-1 3435 M5). Mutation of the PEA3 site (uPA M7) or use of a truncated oligonucleotide completely lacking the PEA3 site (uPA CRE) did not affect the formation of these complexes. Thus, the major proteins detectable under the conditions used bind only to the AP-1 half of the element. The possibility that phosphorylation may be necessary for factor binding to the PEA3 half was considered, but inclusion of phosphatase inhibitors in extraction and binding buffers did not alter the pattern of binding (25) . Incubation of CSF-1-treated BMM nuclear extract with an oligonucleotide able to bind AP-1 yielded one band (Fig. 6B) . Cold uPA wt oligonucleotide was able to compete for proteins binding to the AP-1 site but was a little less efficient than self-competition with cold AP-1 oligonucleotide. Mutation of the AP-1 half of the uPA element (M8) abolished this competition, whereas mutation of the PEA3 half (M5) did not. Thus, the octameric site in the uPA PEA3/AP-1 element (TGAG GTCA) can bind some of the same factors which bind to a conventional AP-1 site (TGAGTCA).
Treatment of BMM with CSF-1 or PMA increased the levels of proteins binding to the AP-1 oligonucleotide (Fig. 6C) . With CSF-1 treatment, levels were highest at 1 h and subsequently declined. However, CSF-1 and PMA did not synergize to increase AP-1 binding activity. In fact, CSF-1 pretreatment prevented induction of AP-1 binding activity by PMA. The same pattern of inductions was found with labelled uPA wt oligonucleotide, although the degree of induction was less pronounced (result not shown). The low level of protein binding in extracts from cells treated with CSF-1 and PMA together indicates that uPA promoter activity does not correlate directly with the induction of AP-1 binding activity.
DNA binding of Ets-1 and Ets-2 is known to be impeded by a repressive domain under the conditions of EMSA (67) . Highaffinity binding may require either posttranslational modification or protein-protein interaction to relieve this repressive 4 U of CSF-1 per ml for 3 h. Nuclear protein (4.5 g) was incubated with four different oligonucleotide probes labelled to achieve the same specific activity. Binding reactions were run on a 5% acrylamide gel. Lane wt probe, no protein extract. Arrows indicate protein-DNA complexes. (B) Competition for proteins binding to a labelled AP-1 oligonucleotide. AP-1 oligonucleotide was mixed with the indicated fold molar excess of cold competitor before the addition of 1 g of nuclear protein. Nuclear extract was made from BMM grown in the presence of CSF-1. Binding reactions were run on a 6% polyacrylamide gel. Free probe has been run off the bottom of the gel. Lane no comp., no competing cold oligonucleotide. (C) Effect of treatment of BMM with CSF-1 and PMA on AP-1 binding. BMM were either starved of CSF-1 overnight (ϪCSF-1 O/N) and subsequently treated with CSF-1 for 1 or 3 h or with PMA for 1 h or left with continued CSF-1 stimulation (ϩCSF-1 O/N) and subsequently treated with PMA for 1 h (ϩCSF-1 O/N ϩPMA 1hr). Nuclear protein (1 g) was incubated with labelled AP-1 oligonucleotide before being run on a 5% polyacrylamide gel. Oligonucleotides used were as follows: AP-1, 5ЈCGCTTGATGAGTCAGCCGGAA3Ј (Promega); uPA wt, 5ЈGGCCAGGAG GAAATGAGGTCATCTTGCT3Ј (uPA PEA3/AP-1); uPA M5, 5ЈGGCCAG GAGGAAATGAGGAGATCTTGCT3Ј (AP-1 mutant); uPA M7, 5ЈGGCCAG TACCAAATGAGGTCATCTTGCT3Ј (PEA3 mutant); uPA M8, 5ЈGGCCAG GACCAAATGAGGTCATCTTGCT3Ј (PEA3 mutant); and uPA CRE, 5ЈGA AATGAGGTCATCTTGCT3Ј (AP-1 half-site).
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effect. Perhaps because of this problem and the lack of good supershifting antibodies specific for Ets-2, to our knowledge native Ets-2 binding activity in nuclear extracts has not been clearly identified. Even using a consensus sequence determined for binding of recombinant Ets-2 DNA binding domain (44), we could not detect a PMA-or CSF-1-inducible protein in macrophages (result not shown), although ets-2 mRNA is clearly induced (Fig. 1) . To examine whether Ets-2 can bind the uPA PEA3/AP-1 element, the DNA binding domain alone was expressed as a GST fusion protein. Figure 7A shows that the Ets-2 DNA binding domain binds the uPA wt oligonucleotide and can be competed for by the AP-1 mutant (uPA M5) and an Ets-2 consensus oligonucleotide but not by the PEA3 mutant (uPA M8). On the basis of competition with increasing concentrations of cold oligonucleotides, the uPA wt sequence was evidently a much lower-affinity site for Ets-2 binding than the Ets-2 consensus sequence (Fig. 7B) .
DISCUSSION
A PEA3/AP-1 element was first identified in the polyomavirus enhancer. It mediated responses to serum, PMA, and the v-src, Ha-ras, v-mos, v-raf, and polyomavirus middle-T-antigen oncogenes (80) and has been termed a tetradecanoyl phorbol acetate-and oncogene-responsive unit (28) . Similar elements have been found in other genes such as collagenase (28), transforming growth factor ␤ (50, 54), the NVL3 retrotransposon (54), keratin 18 (51), uPA (56) , and the macrophage scavenger receptor (82) (Fig. 8) . These elements have all been characterized as ras-responsive elements. Although Rørth et al. (56) mention that ras transformation of keratinocytes did not activate the uPA PEA3/AP-1 element, the element responded strongly to activated ras in NIH 3T3 cells (16) and RAW264 macrophages (25) . The collagenase and keratin 18 PEA3 and AP-1 elements are more widely spaced (Fig. 8) , but it is interesting that the insertion of 10 bp in both cases corresponds to one turn of the DNA helix and may give a similar orientation of binding factors.
As noted in the introduction, the uPA PEA3/AP-1 site at Ϫ2430 in the mouse promoter mediates induction by signals such as epidermal growth factor, PMA, and basic fibroblast growth factor. In this work we have found that the uPA PEA3/ AP-1 element is involved in the transcriptional response to CSF-1 in NIH 3T3/c-fms. Both halves of the element were required for efficient activation of transcription by either v-fms or c-fms with CSF-1 (Fig. 5) . This may reflect the fact that the PEA3 and AP-1 halves are comparatively weak binding sites for Ets and AP-1 proteins (Fig. 6 and 7) . Induction of uPA mRNA by CSF-1 was prevented by both a dominant negative Ets protein (Fig. 4) and the catalytic domain of GAP (16) . uPA induction by CSF-1 in this cell line therefore appears to involve ras signalling and activation of Ets transcription factors. This makes uPA regulation similar to that of both the NVL3 retrotransposon and c-myc (6, 7, 39, 61) . Work on the induction of the NVL3 retrotransposon by CSF-1 in NIH 3T3/c-fms identified a PEA3/AP-1-like element mediating the CSF-1 response (7, 54) . This element had been previously identified as a ras-responsive element (49) . Another CSF-1-inducible gene, the macrophage scavenger receptor gene, contains a similar ras-and PMA-responsive element, although this element has not yet been directly shown to be activated by CSF-1 (82) .
Comparison of the NVL3, uPA, and scavenger receptor PEA3/ AP-1 elements (Fig. 8) shows similar spacings of elements but a number of sequence differences. Wu et al. (82) found that Ets-2, but not Ets-1, was able to transactivate the scavenger receptor element and to cooperate with c-Jun. This differs from results for the uPA element in RAW264 cells, in which Ets-2 and Ets-1 have similar activities. VOL. 15, 1995 REGULATION OF UROKINASE EXPRESSION BY CSF-1
Introduction of a mutation at Tyr-809 in the CSF-1R prevents induction of c-myc, the NVL3 gene, and the mitogenic response in NIH 3T3/c-fms treated with CSF-1 (39, 60, 64) . These effects are mimicked by the expression of dominant negative Ets-2 (39). CSF-1-induced mitogenesis can be restored to cells with the Tyr-809 mutation by the expression of ets-1, ets-2, or c-myc (39, 60, 61) , and induction of c-myc appears to involve Ets factors (61) . This implicates an Ets factor with binding specificity and activity similar to those of Ets-1 and Ets-2 in the CSF-1 signalling pathway in these cells. The identification of the NVL3 and uPA PEA3/AP-1 sequences as promoter targets of CSF-1 is an important step towards finding the specific transcription factors involved in signalling.
The 3Ј half of the uPA PEA3/AP-1 site is octameric and more closely resembles a CRE (TGACGTCA) than it does the consensus AP-1 site (TGA[C/G]TCA). The distinction between CRE and AP-1 sites has become blurred by the findings that AP-1 factors can dimerize with the CRE-binding factors (CREB/ATF family) (29) and that AP-1 factors themselves can also bind to octameric sequences (1, 65) . The wide range of Ets family proteins and AP-1 and CREB/ATF proteins makes the determination of which factors bind these elements a challenge. The octameric site in uPA is not responsive to cAMP and functions similarly to an AP-1 site (40) . In extracts from pig kidney epithelial cells, c-Jun has been found to bind the pig uPA PEA3/AP-1 element (41). In another study, a c-Jun/ATF2 heterodimer has been shown to bind the AP-1 half of the uPA PEA3/AP-1 element (19) . Macrophage AP-1-binding factors will also clearly bind to the octameric uPA AP-1 sequence (Fig.  6) , although with slightly lower affinity than to a conventional AP-1 site. When either a labelled AP-1 oligonucleotide (Fig.  6C) or the uPA PEA3/AP-1 element (25) was used, treatment with CSF-1 or PMA increased levels of AP-1 factor binding. However, CSF-1 pretreatment prevented induction of AP-1 factors by PMA. Hence, the synergy seen in induction of uPA mRNA (Fig. 1) is not due to synergistic induction of general AP-1 binding activity.
The effect of PEA3 site mutation in transient-expression analysis (Fig. 3) showed that this element was functionally important. Despite this, with EMSA we were unable to detect any strong binding of macrophage nuclear factors to the PEA3 half of the uPA element. The two major detectable bands were both accounted for by proteins binding to the AP-1 site (Fig.  6 ). Conditions used in making nuclear protein extracts or in EMSA may be inadequate for detecting factors binding to the PEA3 site. In EMSA with extract from pig kidney LLC-PK 1 cells, only one complex was observed; this result was explainable by c-Jun binding to the AP-1 half of the pig uPA PEA3/ AP-1 element (41). However, in vivo footprinting showed the uPA PEA3 site to be constitutively occupied regardless of enhancer activity (46) . Owen and Ostrowski (50) found a 120-kDa protein in NIH 3T3 which can bind to the NVL3 PEA3 site and does not correspond to known Ets factors. In studies of the scavenger receptor element, large amounts of protein were required before evidence of binding to the PEA3 half of the element was observed (82) .
Mutation of the PEA3 site reduced the high level of transactivation by Ets-2 (Fig. 3C) , suggesting that Ets-2 acts through this site. Bacterially expressed Ets-2 DNA binding domain was clearly capable of binding to this element, but it is a loweraffinity site than the consensus Ets-2 binding site (Fig. 7) . It is impossible to determine what represents sufficient affinity to be of biological relevance, especially as the uPA site is a compound element and cooperative binding could increase the effective affinity. The evidence that Ets-2 can transactivate through this site, is capable of binding to it, and is induced by CSF-1 makes it a good candidate for a normal regulator of uPA in vivo.
The macrophage cell line RAW264 can be readily transfected and responds to CSF-1 with a three-to sixfold induction of uPA mRNA ( Fig. 1) (71, 72) . In contrast to that of BMM, this induction did not seem to be mediated at the transcriptional level (Fig. 2) . The rate of transcription of uPA in RAW264 cells was low compared with that in CSF-1-stimulated BMM (Fig. 2) , leading us to propose that in RAW264 cells there is a deficiency in the CSF-1 signal transduction pathway leading to uPA gene transcription. Recent results comparing protein tyrosine phosphorylation levels in RAW264 cells and BMM show similar levels of induction of phosphorylation by CSF-1 in the two cell types, including phosphorylation of mitogen-activated protein kinases (25) . Thus, there appears to be no fundamental defect in CSF-1R function in RAW264 cells. RAW264 cells are transformed by Abelson leukemia virus, which presumably encodes an active v-abl tyrosine kinase. This tyrosine kinase activity may lead to the down-regulation of a factor in the CSF-1 signalling pathway.
A simple hypothesis to account for the poor level of induction of uPA by CSF-1 in RAW264 cells is that uPA transcription is regulated by Ets-2 and CSF-1 fails to induce ets-2 mRNA efficiently in the cell line (Fig. 1) . If Ets-2 is involved in the normal regulation of the uPA gene, then the synergistic induction of uPA mRNA by CSF-1 and PMA could be at least partly accounted for by synergistic effects of the two agents on ets-2 mRNA levels (Fig. 1 ).
An alternative interpretation is that ets-2 and uPA are regulated in parallel, via the activation of another Ets protein.
However, the time course of ets-2 mRNA induction and decay is quite different from that for uPA (25) . The ets-2 gene promoter itself contains an Ets factor binding site involved in expression of the gene, and protein binding to an adjacent promoter element was competed for, although not efficiently, by an AP-1 oligonucleotide (45) . Whether this element functions in the same way as the uPA element remains to be established. Other Ets factors expressed in macrophages include PU.1 (57), Elf-1 (32), and Fli-1 (36) . Neither PU.1 nor Elf-1 was able to effectively transactivate the uPA promoter (Fig. 3D) , although the uPA PEA3 element is similar to a published Elf-1 binding site (AGGAGGAAAA [74] ) and an Elf-1 binding site is closely associated with an AP-1 site in the human interleukin-3 gene (27) .
Although analysis of the CSF-1 response in transfected RAW264 cells was not possible, the PEA3/AP-1 element was identified as a PMA-responsive element in this cell line (Fig.  3B) . The same element mediated a response to PMA in keratinocytes (56) and in the pig kidney epithelial cell line LLC-PK 1 (41) . In HepG2 hepatoma cells, the cooperation between the PEA3/AP-1 site and a downstream AP-1 site was necessary for induction by PMA (47) .
Although both PMA and CSF-1 are able to activate the PEA3/AP-1 element, the evidence does not support the hypothesis that the pathways of activation are coincident. Both the synergy between CSF-1 and PMA in induction of uPA mRNA in BMM (Fig. 1) and the differential response of RAW264 cells to CSF-1 and PMA in transient transfections suggest that CSF-1 and PMA induce uPA by distinct mechanisms. PMA does not mimic the action of CSF-1. The two agonists may activate separate pathways or may have synergistic effects on the one signalling pathway. Although some evidence that CSF-1 activates PKC has been presented (34, 66) , a recent study suggests that PKC activation is not significant, at least not in early signalling by CSF-1 (35) . Like CSF-1 (2), PMA and PKC can activate Raf-1 (38) . It will be interesting to 3438 STACEY ET AL. MOL. CELL. BIOL.
ascertain whether PMA can increase Raf-1 activation when added to CSF-1-treated cells. PMA is frequently used in promoter studies without indication of its physiological relevance. There may be natural stimuli which act through PKC and strongly enhance the induction of uPA by CSF-1. Transforming growth factor ␤ induces uPA in RAW264 cells and may act through a PKC-dependent mechanism (24) . It is also possible that PMA provides a combination of stimuli to cells which does not resemble the action of any physiological molecule.
In this work we have provided evidence that the CSF-1 response of the uPA gene is distinct from the response to PMA, is mediated through a PEA3/AP-1 element, and requires activation of an Ets transcription factor, possibly Ets-2. Earlier evidence pointed to bifurcating signalling pathways from the CSF-1 receptor, one through ras, raf, Ets, and myc factors and another leading to induction of fos and jun proteins (7, 9, 39, 60) . Although ras is generally considered an activator of Raf-1, recent work showed that ras and Raf-1 were activated independently by CSF-1 in the macrophage cell line BAC1.2F5 (10) and are therefore likely to be part of cooperating but separate pathways. Since expression of v-raf in BAC1.2F5 macrophages leads to constitutive expression of ets-2 mRNA (9), induction of ets-2 by CSF-1 may be due to activation of a pathway involving Raf-1. We have found that coexpressed Ets-2 and activated ras in RAW264 cells synergistically increase uPA promoter activity (25) . This is consistent with a model in which a Raf-1-activated pathway induces Ets-2 expression and ras either activates Ets-2 or induces cooperating factors.
Many studies of the CSF-1 signal transduction pathway have been performed with fibroblasts expressing the CSF-1R. This is partly due to the difficulties of transfection and manipulation of macrophages. In this study we have used NIH 3T3 cells expressing c-fms, as the transfectable macrophage cell lines available to us did not respond adequately to CSF-1 with transcriptional activation of the uPA gene. Differences in CSF-1 signalling between fibroblasts and macrophages have been detected (43) , and the challenge remains to confirm with macrophages the results of numerous studies performed with fibroblasts.
